Comprehensive Smoke-Free Laws and Cardiovascular Disease Mortality in US Counties
-
By
-
Chuyue Wu
-
Mina Habib
-
Nathan D. Wong
-
Tony Kuo
-
Roch A. Nianogo
-
June 24, 2026
-
Clinical Scorecard: Impact of Comprehensive Smoke-Free Legislation on Cardiovascular Disease Mortality Rates in US Counties
At a Glance
| Category | Detail |
| Condition | Cardiovascular Disease (CVD) |
| Key Mechanisms | Comprehensive smoke-free laws reduce exposure to secondhand smoke (SHS) and active smoking behaviors. |
| Target Population | US counties with varying sociodemographic characteristics. |
| Care Setting | Public health and tobacco control policy evaluation. |
Key Highlights
- CVD is the leading cause of death in the US, with persistent disparities across sociodemographic groups.
- Comprehensive smoke-free laws are associated with reductions in CVD mortality.
- The study utilized generalized synthetic control method (GSCM) to evaluate long-term effects.
- Disparities in SHS exposure persist among non-Hispanic Black individuals and those with lower socioeconomic status.
- The study analyzed data from 2000 to 2018 across 38 treated and 103 control counties.
Guideline-Based Recommendations
Diagnosis
- CVD mortality rates should be monitored using age-adjusted metrics.
Management
- Implement comprehensive smoke-free laws to reduce CVD mortality.
Monitoring & Follow-up
- Evaluate the impact of smoke-free laws on CVD mortality over time.
Risks
- Active smoking and SHS exposure are significant risk factors for CVD.
Patient & Prescribing Data
Counties with comprehensive smoke-free laws.
Long-term reductions in CVD mortality associated with smoke-free legislation.
Clinical Best Practices
- Adopt comprehensive smoke-free policies in public venues.
- Ensure equitable enforcement of smoke-free laws across different populations.
Related Resources & Content